Genvax Technologies

Startup

Genvax (GV) utilizes self-amplifying messenger RNA (saRNA) combined nanoparticles to manufacture vaccines for the prevention of infectious diseases in animals. An emphasis will be placed on creating herd-specific vaccines that can be rapidly deployed to match the genetic sequence of pathogens occurring in livestock operations.